Assetmark »

Corcept Therapeutics Incorporated shares owned by Assetmark

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Assetmark

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 56k 32.48
2023-09-30 $475k 17k 27.25
2023-06-30 $992k 45k 22.25
2023-03-31 $910k 42k 21.66
2022-12-31 $786k 39k 20.31
2022-09-30 $964k 38k 25.64
2022-06-30 $879k 37k 23.77
2022-03-31 $756k 34k 22.51
2021-12-31 $749k 38k 19.81
2021-09-30 $1.3M 64k 19.68
2021-06-30 $1.3M 58k 21.99
2021-03-31 $673k 28k 23.78
2020-12-31 $681k 26k 26.15
2020-09-30 $828k 48k 17.40
2020-06-30 $153k 9.1k 16.85